Insights from Digital Pharma Leaders
Refine Search
Pharmaceutical
In a highly informative and useful Expert View piece, Heather Longden, senior marketing manager for informatics regulatory compliance at the analytical laboratory instrument and software company Waters Corporation, provides insights into the vital role data integrity plays when it comes to analytical testing for drug development. 26 January 2018
Pharmaceutical
Andrew Rut, chief executive of MyMeds&Me, a provider of adverse event and product quality capture software, considers in an Expert View piece how pharma’s ability to run efficient clinical trials is in danger of being compromised by GDPR and a hardening of attitudes on data privacy globally. 9 January 2018
Pharmaceutical
German pharma major Boehringer Ingelheim has increased the size of its corporate venture fund to 250 million euros ($301 million). 3 January 2018
Pharmaceutical
In an area like oncology, innovation is needed not just with the end product, but in the way that researchers get there, finds Rik Van Mol, vice president of R&D strategy at software provider Veeva Systems, in an Expert View piece looking at a leading cancer charity’s modernization of clinical operations. 15 November 2017
Pharmaceutical
The US Food and Drug Administration (FDA) has approved the first drug with a digital ingestion tracking system. 14 November 2017
Pharmaceutical
As many as 97% of life science companies expect to use more clinical data from a wider variety of sources over the next three years to make faster, more accurate decisions during trials, according to new research from Tufts Center for the Study of Drug Development. 7 November 2017
Pharmaceutical
Bayer has entered into a strategic partnership with the healthcare division of Chinese tech company Alibaba Group, giving the German firm access to large amounts of customer data from the Alibaba platform. 23 October 2017
Pharmaceutical
The pharma unit of US healthcare giant Johnson & Johnson has announced that it is embarking on a world first for the drug industry. 11 October 2017
Pharmaceutical
German life sciences company Merck KGaA on Sunday became the latest pharma major to back the big data revolution that some believe will transform healthcare. 11 September 2017
Pharmaceutical
Switzerland’s Novartis has appointed Bertrand Bodson as chief digital officer, reporting directly to the CEO. 24 August 2017
Pharmaceutical
When facing an illness, one of the first things that patients and caregivers do is go online for information, writes Dawn Lacallade, chief social strategist and pharma practice lead at social media specialist LiveWorld, in an Expert View piece. 15 August 2017
Pharmaceutical
Twenty-first century data is providing the data-heavy pharma industry with a modern dilemma: how to preserve corporate information when technological development is accelerating so fast, writes Dominic Johnstone, head of information management services at Crown Records Management. 1 August 2017
Pharmaceutical
In an Expert View piece, Annie Sullivan, director of corporate social media at Anglo-Swedish pharma major AstraZeneca, discusses the company’s novel approach of being 'a better social media citizen' and how its adoption of this strategy at the ASCO Annual Meeting in 2017 may help evolve the role of pharma on social media. 31 July 2017
Pharmaceutical
A new report into the use of digital technology by the pharmaceutical industry details increased production of mobile apps, but stagnation in the growth of app downloads. 25 July 2017
Pharmaceutical
The pharmaceutical industry is a prime target for hackers. In 2015, a survey by Crown Records Management revealed that nearly two thirds of pharma firms had experienced breaches in data, and that one fourth of these same companies had been victims of hacking. 18 July 2017
Pharmaceutical
The UK government is to provide £86 million in funding to support British firms in developing medical technologies. 14 July 2017
Pharmaceutical
The growing number of clinical trials and increasing complexity across the clinical lifecycle are putting pressure on life sciences organizations to improve study quality and execution, writes Rik Van Mol, vice president of R&D strategy, Europe, Veeva Systems, in an Expert View piece. 4 July 2017
Pharmaceutical
The interim president and chief executive of Teva Pharmaceutical, Yitzhak Peterburg, has said that he believes the healthcare industry is undergoing “huge disruption.” 29 June 2017
Pharmaceutical
Todd Greenwood, director of digital Strategy at digital health specialists Medullan, provides an expert view on the value of real-world evidence and patient support in the successful implementation of a value-based approach to healthcare. 26 June 2017
Pharmaceutical
The dramatic availability of new data sources along with the opportunity to leverage existing data pools, is radically changing the way we think about clinical trials, writes Mike Capone, chief operating officer of Medidata, the provider of cloud-based solutions for clinical research, in an Expert View piece. 14 June 2017
Pharmaceutical
Precision medicine has advanced significantly over the past decade, driven by breakthroughs in chemical, hardware, software, and especially cloud computing technologies. 18 March 2025
Biotechnology
MeiraGTx has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the Phase III development of AAV-GAD, a gene therapy for Parkinson’s disease. 13 March 2025
Pharmaceutical
Insilico Medicine has raised $110 million in a series E funding round to drive the development of its artificial intelligence-powered drug candidates, including its leading drug for idiopathic pulmonary fibrosis (IPF). 13 March 2025
Pharmaceutical
Germany’s Boehringer Ingelheim has launched the One Medicine Platform, a new system designed to streamline drug development, following the implementation of Veeva Systems' Development Cloud. 12 March 2025
Biotechnology
Nona Biosciences has introduced Hu-mAtrIx, an AI-assisted drug discovery platform designed to accelerate the identification and development of antibody-based therapies. 7 March 2025
Pharmaceutical
The new US President has repealed an executive order from October 2023, signed by the Biden administration, that sought to establish rigorous safeguards for artificial intelligence (AI) development. 22 February 2025
Pharmaceutical
US biopharma Incyte and privately-held AI-focused biotech Genesis Therapeutics have entered into a strategic collaboration focused on the research, discovery and development of novel small molecule medicines. 21 February 2025
Pharmaceutical
An Expert View from Kevin Wild, head of pre-sales at software company Syniti. 23 January 2025
Pharmaceutical
French pharmaceutical company Servier and Google Cloud have announced an expanded five-year partnership aimed at leveraging artificial intelligence (AI) and generative AI to accelerate drug research and development. 16 January 2025
Pharmaceutical
A collection of some of the largest US health systems, in collaboration with the Regeneron Genetics Center, have announced the launch of the Truveta Genome Project. 16 January 2025
Pharmaceutical
Privately-held Italian drugmaker Menarini and its oncology-focused subsidiary Stemline Therapeutics have entered into a licensing deal with AI-driven biotech Insilico Medicines. 15 January 2025
Biotechnology
Dyno Therapeutics, a privately-held US genetic technologies company applying AI to enable in vivo gene delivery, has announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed neurological disease indication. 13 January 2025
Pharmaceutical
Real-world evidence (RWE) specialist Atropos Health has announced a collaboration with US pharma giant Merck & Co. 13 January 2025
Biotechnology
Belgian biopharmaceutical company UCB has entered into a license agreement with Ailux Biologics, the biologics discovery division of XtalPi, to leverage its AI platform. 9 January 2025
Pharmaceutical
Insilico Medicine, a biotechnology firm specializing in artificial intelligence-powered drug discovery, has raised over $100 million in a series E funding round. 8 January 2025
Pharmaceutical
A team of Chinese researchers has identified a promising candidate for glaucoma treatment using artificial intelligence tools. 6 January 2025
Pharmaceutical
The market for artificial intelligence (AI) in cancer care is projected to grow from $2.2 billion in 2024 to $6.3 billion by 2029, reflecting a growth rate of 23.1%, according to a recent study by BCC Research. 31 December 2024
Biotechnology
AI-driven biotech BenevolentAI has announced sweeping changes aimed at refocusing its operations and extending its financial runway into 2027. 20 December 2024
Pharmaceutical
Shanghai-based Fangzhou, has entered into a strategic partnership with the Chinese business of Bristol Myers Squibb China, with the goal of enhancing digital platforms for chronic disease management. 19 December 2024
Pharmaceutical
Swedish biotech company Inify Laboratories has raised approximately 135 million kroner ($12.3 million) through a private placement, supporting a planned expansion into the UK. 16 December 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze